Phase III DIPPER trial shows that adjuvant camrelizumab administered after induction-concurrent chemoradiotherapy ...

In this video interview, Cameron Breze, product manager, Inovalon, discusses the need for accurate information in creating ...

The pivotal Phase III study in myasthenia gravis met its primary endpoint with meaningful improvements in MG-ADL across both higher and lower dose arms.

Recent research is showing medical treatment for pregnant women often relies on clinical data from non-pregnant female ...

In this video interview, Cameron Breze, product manager, Inovalon, discusses current challenges with patient recruitment and ...

New data from the Phase II RAINFOL-01 study shows rinatabart sesutecan (Rina-S), an investigative antibody-drug conjugate, ...

In today’s clinical trials, compared to those of the past, there is increasing complexity, greater data collection, and a ...

FDA grants Fast Track designation to Johnson & Johnson’s investigational therapy nipocalimab for the treatment of moderate-to-severe Sjögren’s disease, which could be the first targeted therapy ever ...

In this video interview, Cameron Breze, product manager, Inovalon, talks clinical technology and how the industry is working to increase comfortability with its implementation.

This year’s conference highlighted a number of critical areas in clinical R&D including financial management, representation, ...

In this video interview, Yael Elish, founder, CEO, StuffThatWorks; and Julie Ross, president, CEO, Advanced Clinical, talk ...

In this video interview, Yael Elish, founder, CEO, StuffThatWorks; and Julie Ross, president, CEO, Advanced Clinical, ...